JL
Insider
Joel Lewis
President and CEOJoel Lewis (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $243K of GALT (65,429 sh across 2 lots, as filed), executed Jan 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$243K
shares × price, as filed
Last traded
Jan 6
Filed Jan 6
Median ADV $2.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $243K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
GALTRecent filings
GALTSALE
Galectin Therapeutics Inc.
View filing →
$243K65,429 sh across 2 lots
Exec Jan 5
Filed Jan 6 · 5:30 PM ET